Abstract |
Psychostimulants, including amphetamine, act as antihyperkinetic agents in humans with hyperkinetic disorder such as attention-deficit hyperactivity disorder and are known to be effective in enhancing attention-related processes; however, the underlying mechanisms have not been adequately addressed. Mice lacking the Adcyap1 gene encoding the neuropeptide pituitary adenylate cyclase-activating polypeptide (Adcyap1(-/-)) display psychomotor abnormalities, including increased novelty-seeking behavior and hyperactivity. In this study, Adcyap1(-/-) mice showed sensory-motor gating deficits, measured as deficits in prepulse inhibition (PPI), and showed normal PPI in response to amphetamine. Amphetamine also significantly decreased hyperlocomotion in Adcyap1(-/-) mice, and this paradoxical antihyperkinetic effect depended on serotonin 1A (5-HT(1A)) receptor signaling. c-Fos-positive neurons were increased in the prefrontal cortex in amphetamine-treated Adcyap1(-/-) mice, suggesting increased inhibitory control by prefrontal neurons. Additionally, amphetamine produced an antihyperkinetic effect in wild-type mice that received the 5-HT(1A) agonist 8-hydroxy-2-(di-n-propylamino)tetralin. These results indicate that Adcyap1(-/-) mice act as a model of hyperlocomotion and PPI deficits and suggest that 5-HT(1A)-mediated pathways are important determinants of the psychostimulant-elicited, rate-dependent effects that are in a negative function of the baseline rate of activity.
|
Authors | Kazuhiro Tanaka, Norihito Shintani, Hitoshi Hashimoto, Naofumi Kawagishi, Yukio Ago, Toshio Matsuda, Ryota Hashimoto, Hiroshi Kunugi, Akiko Yamamoto, Chihiro Kawaguchi, Takeshi Shimada, Akemichi Baba |
Journal | The Journal of neuroscience : the official journal of the Society for Neuroscience
(J Neurosci)
Vol. 26
Issue 19
Pg. 5091-7
(May 10 2006)
ISSN: 1529-2401 [Electronic] United States |
PMID | 16687500
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adcyap1 protein, mouse
- Central Nervous System Stimulants
- Pituitary Adenylate Cyclase-Activating Polypeptide
- Amphetamine
|
Topics |
- Acoustic Stimulation
(methods)
- Amphetamine
(administration & dosage)
- Animals
- Central Nervous System Stimulants
(administration & dosage)
- Hyperkinesis
(drug therapy, physiopathology)
- Mice
- Pituitary Adenylate Cyclase-Activating Polypeptide
(deficiency, metabolism)
- Reaction Time
(drug effects)
- Reflex, Startle
(drug effects)
|